|
| 37939105 | Paclitaxel plus Eftilagimod Alpha, a Soluble LAG-3 Protein, in Metastatic, HR+ Breast Cancer: Results from AIPAC, a Randomized, Placebo Controlled Phase IIb Trial. | Clin Cancer Res | 2024 |
| 36031469 | Tumor biology reflected by histological growth pattern is more important than surgical margin for the prognosis of patients undergoing resection of colorectal liver metastases. | Eur J Surg Oncol | 2023 |
| 37965465 | Histopathological growth pattern of liver metastases as an independent marker of metastatic behavior in different primary cancers. | Front Oncol | 2023 |
| 37596278 | An idiosyncratic zonated stroma encapsulates desmoplastic liver metastases and originates from injured liver. | Nat Commun | 2023 |
| 37573673 | Association of body mass index with clinicopathological features and survival in patients with primary invasive lobular breast cancer. | Eur J Cancer | 2023 |
| 37236636 | First-in-human phase Ib trial of M9241 (NHS-IL12) plus avelumab in patients with advanced solid tumors, including dose expansion in patients with advanced urothelial carcinoma. | J Immunother Cancer | 2023 |
| 36717676 | Comment on 'Use the term "infiltrative" instead of "replacement" when defining histopathological growth pattern in patients with liver cancer' by Kong B et al. | Br J Cancer | 2023 |
| 36717329 | Comparison of the genomic alterations present in tumor samples from patients with metastatic inflammatory versus non-inflammatory breast cancer reveals AURKA as a potential treatment target. | Breast | 2023 |
| 36368320 | Challenges in neoantigen-directed therapeutics. | Cancer Cell | 2023 |
| 34844889 | The Place of Chemotherapy in The Evolving Treatment Landscape for Patients With HR-positive/HER2-negative MBC. | Clin Breast Cancer | 2022 |
| 35650276 | Histopathological growth patterns of liver metastasis: updated consensus guidelines for pattern scoring, perspectives and recent mechanistic insights. | Br J Cancer | 2022 |
| 35397078 | Circulating tumor cell detection: A prospective comparison between CellSearch® and RareCyte® platforms in patients with progressive metastatic breast cancer. | Breast Cancer Res Treat | 2022 |
| 35790747 | Interrogating breast cancer heterogeneity using single and pooled circulating tumor cell analysis. | NPJ Breast Cancer | 2022 |
| 35526835 | Discordance between Immunohistochemistry and Erb-B2 Receptor Tyrosine Kinase 2 mRNA to Determine Human Epidermal Growth Factor Receptor 2 Low Status for Breast Cancer. | J Mol Diagn | 2022 |
| 35132503 | Coagulation/fibrinolysis and circulating tumor cells in patients with advanced breast cancer. | Breast Cancer Res Treat | 2022 |
| 34921020 | Assessing CSF ctDNA to Improve Diagnostic Accuracy and Therapeutic Monitoring in Breast Cancer Leptomeningeal Metastasis. | Clin Cancer Res | 2022 |
| 35042871 | Comparative transcriptional analyses of preclinical models and patient samples reveal MYC and RELA driven expression patterns that define the molecular landscape of IBC. | NPJ Breast Cancer | 2022 |
| 35278078 | Modeling the Prognostic Impact of Circulating Tumor Cells Enumeration in Metastatic Breast Cancer for Clinical Trial Design Simulation. | Oncologist | 2022 |
| 35063943 | Prospective non-interventional BELOVA/BGOG-ov16 study on safety of frontline bevacizumab in elderly patients with FIGO stage IV ovarian cancer: a study of the Belgian and Luxembourg Gynaecological Oncology Group. | Int J Gynecol Cancer | 2022 |
| 32735852 | Can medical imaging identify the histopathological growth patterns of liver metastases? | Semin Cancer Biol | 2021 |
| 33655422 | Type IV collagen as a potential biomarker of metastatic breast cancer. | Clin Exp Metastasis | 2021 |
| 33852104 | A phase 1a/1b trial of CSF-1R inhibitor LY3022855 in combination with durvalumab or tremelimumab in patients with advanced solid tumors. | Invest New Drugs | 2021 |
| 33808193 | Increased Pathway Complexity Is a Prognostic Biomarker in Metastatic Castration-Resistant Prostate Cancer. | Cancers (Basel) | 2021 |
| 33751583 | Clinico-metabolic characterization improves the prognostic value of histological growth patterns in patients undergoing surgery for colorectal liver metastases. | J Surg Oncol | 2021 |
| 34133923 | Tumor vessel co-option probed by single-cell analysis. | Cell Rep | 2021 |
| 34104544 | Immune landscape of inflammatory breast cancer suggests vulnerability to immune checkpoint inhibitors. | Oncoimmunology | 2021 |
| 34238931 | Comparative survival analysis of multiparametric tests-when molecular tests disagree-A TEAM Pathology study. | NPJ Breast Cancer | 2021 |
| 33307151 | Stereotactic Ablative Radiation Therapy to All Lesions in Patients With Oligometastatic Cancers: A Phase 1 Dose-Escalation Trial. | Int J Radiat Oncol Biol Phys | 2021 |
| 33230201 | Automated enumeration and phenotypic characterization of CTCs and tdEVs in patients with metastatic castration resistant prostate cancer. | Prostate Cancer Prostatic Dis | 2021 |
| 32770247 | Serial Analysis of Circulating Tumor Cells in Metastatic Breast Cancer Receiving First-Line Chemotherapy. | J Natl Cancer Inst | 2021 |
| 32423453 | Quantitative hormone receptor (HR) expression and gene expression analysis in HR+ inflammatory breast cancer (IBC) vs non-IBC. | BMC Cancer | 2020 |
| 31801732 | Efficacy and Tolerability of Tremelimumab in Locally Advanced or Metastatic Urothelial Carcinoma Patients Who Have Failed First-Line Platinum-Based Chemotherapy. | Clin Cancer Res | 2020 |
| 32043194 | Inflammatory breast cancer cells are characterized by abrogated TGFβ1-dependent cell motility and SMAD3 activity. | Breast Cancer Res Treat | 2020 |
| 31655928 | Pathological features of vessel co-option versus sprouting angiogenesis. | Angiogenesis | 2020 |
| 31854063 | NOTCH and DNA repair pathways are more frequently targeted by genomic alterations in inflammatory than in non-inflammatory breast cancers. | Mol Oncol | 2020 |
| 33339824 | Association between the histopathological growth patterns of liver metastases and survival after hepatic surgery in breast cancer patients. | NPJ Breast Cancer | 2020 |
| 33037118 | Avelumab as second-line therapy for metastatic, platinum-treated urothelial carcinoma in the phase Ib JAVELIN Solid Tumor study: 2-year updated efficacy and safety analysis. | J Immunother Cancer | 2020 |
| 32890963 | A high neutrophil-lymphocyte ratio and platelet-lymphocyte ratio are associated with a worse outcome in inflammatory breast cancer. | Breast | 2020 |
| 32998962 | Phase Ib Dose-escalation/Expansion Trial of Ribociclib in Combination With Everolimus and Exemestane in Postmenopausal Women with HR<sup>+</sup>, HER2<sup>-</sup> Advanced Breast Cancer. | Clin Cancer Res | 2020 |
| 32679307 | The use of simulation-CT's as a coronavirus disease 2019 screening tool during the severe acute respiratory syndrome coronavirus 2 pandemic. | Radiother Oncol | 2020 |
| 32356465 | Phase II open-label study investigating apalutamide in patients with biochemical progression after radical prostatectomy. | Future Oncol | 2020 |
| 32205863 | Immune phenotype and histopathological growth pattern in patients with colorectal liver metastases. | Br J Cancer | 2020 |
| 32269140 | Efficacy and safety of avelumab treatment in patients with metastatic Merkel cell carcinoma: experience from a global expanded access program. | J Immunother Cancer | 2020 |
| 30637550 | Angiogenic desmoplastic histopathological growth pattern as a prognostic marker of good outcome in patients with colorectal liver metastases. | Angiogenesis | 2019 |
| 31921184 | Comparative Profiling of Metastatic 4T1- vs. Non-metastatic Py230-Based Mammary Tumors in an Intraductal Model for Triple-Negative Breast Cancer. | Front Immunol | 2019 |
| 30209161 | <i>TP53</i> Outperforms Other Androgen Receptor Biomarkers to Predict Abiraterone or Enzalutamide Outcome in Metastatic Castration-Resistant Prostate Cancer. | Clin Cancer Res | 2019 |
| 31180178 | AR splice variants in circulating tumor cells of patients with castration-resistant prostate cancer: relation with outcome to cabazitaxel. | Mol Oncol | 2019 |
| 31265358 | Predictive Significance of Androgen Receptor Splice Variant 7 in Patients With Metastatic Castration-Resistant Prostate Cancer: The PROPHECY Study. | J Clin Oncol | 2019 |
| 31483799 | HER-2 status of circulating tumor cells in a metastatic breast cancer cohort: A comparative study on characterization techniques. | PLoS One | 2019 |
| 31255421 | Re: Fabian Lohaus, Klaus Zöphel, Steffen Löck, et al. Can Local Ablative Radiotherapy Revert Castration-resistant Prostate Cancer to an Earlier Stage of Disease? Eur Urol 2019;75:548-51. | Eur Urol | 2019 |